Inscobee Decides 5 Billion Won Third-Party Capital Increase at 500 Won per Share for Operating and Debt Repayment
Correction filing on May 19, 2026: Inscobee changes third-party allottee from SM Solution to Nemo Bio Ventures, issuing 10 million shares at 500 won each (total 5 billion won).
Use of proceeds: 2.428 billion won for operating expenses (personnel costs), 2.572 billion won for debt repayment (early redemption of series 32, 35, 36 convertible bonds).
Nemo Bio Ventures' financials: total equity -66 million won (capital impairment), raising concerns about payment ability.
Issue price of 500 won is the par value, applied because the reference price (366.99 won) fell below par.
New shares will be deposited with KSD for a one-year lock-up; listing expected on June 25, 2026.
Post-issuance total shares: 157,886,116, resulting in approximately 6.3% dilution (based on previous 147,886,116 shares).
KOSPI Filing Information
Filing: [Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)